Published in J Cardiovasc Pharmacol on November 01, 2008
Cardiovascular remodelling in coronary artery disease and heart failure. Lancet (2014) 1.47
Diabetic cardiomyopathy: pathophysiology and clinical features. Heart Fail Rev (2013) 1.44
Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations. Basic Res Cardiol (2010) 1.37
Cardioprotection with postconditioning: loss of efficacy in murine models of type-2 and type-1 diabetes. Antioxid Redox Signal (2010) 1.17
Protective ischaemia in patients: preconditioning and postconditioning. Cardiovasc Res (2009) 1.10
The challenge of translating ischemic conditioning from animal models to humans: the role of comorbidities. Dis Model Mech (2014) 0.99
Ischaemic conditioning: pitfalls on the path to clinical translation. Br J Pharmacol (2015) 0.89
Postconditioning signalling in the heart: mechanisms and translatability. Br J Pharmacol (2014) 0.88
Autophagy, myocardial protection, and the metabolic syndrome. J Cardiovasc Pharmacol (2012) 0.88
Ischemic conditioning: the challenge of protecting the diabetic heart. Cardiovasc Diagn Ther (2014) 0.85
Opioid receptors and cardioprotection - 'opioidergic conditioning' of the heart. Br J Pharmacol (2015) 0.85
Diabetes, perioperative ischaemia and volatile anaesthetics: consequences of derangements in myocardial substrate metabolism. Cardiovasc Diabetol (2013) 0.85
Blockade of electron transport before ischemia protects mitochondria and decreases myocardial injury during reperfusion in aged rat hearts. Transl Res (2012) 0.85
Obesity improves myocardial ischaemic tolerance and RISK signalling in insulin-insensitive rats. Dis Model Mech (2012) 0.82
Involvement of Glycogen Synthase Kinase-3β and Oxidation Status in the Loss of Cardioprotection by Postconditioning in Chronic Diabetic Male Rats. Adv Pharm Bull (2015) 0.81
Wnt/Glycogen Synthase Kinase 3β/β-catenin Signaling Activation Mediated Sevoflurane Preconditioning-induced Cardioprotection. Chin Med J (Engl) (2015) 0.80
Inhibition of mitochondrial permeability transition pore restores the cardioprotection by postconditioning in diabetic hearts. J Diabetes Metab Disord (2014) 0.80
The effects of ischemic postconditioning on myocardial function and nitric oxide metabolites following ischemia-reperfusion in hyperthyroid rats. Korean J Physiol Pharmacol (2014) 0.79
Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction. Crit Care Med (2008) 3.50
Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial. JAMA (2007) 3.07
Transcatheter closure of patent foramen ovale in patients with cerebral ischemia. J Am Coll Cardiol (2002) 2.24
Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial. Am Heart J (2012) 1.65
Impedance cardiography as a noninvasive technique for atrioventricular interval optimization in cardiac resynchronization therapy. J Interv Card Electrophysiol (2005) 1.60
Perforation of aortic root as secondary complication after implantation of patent foramen ovale occlusion device in a 31-year-old woman. J Interv Cardiol (2006) 1.60
Caveolin-1 facilitates mechanosensitive protein kinase B (Akt) signaling in vitro and in vivo. Circ Res (2005) 1.55
Regulation of protein kinase C isozyme and calcineurin expression in isoproterenol induced cardiac hypertrophy. J Cardiovasc Pharmacol (2003) 1.49
[Position document on quality assurance in invasive cardiology. Are minimum numbers in percutaneous coronary angioplasty evidence based?]. Z Kardiol (2004) 1.49
Transient global amnesia and broken heart syndrome: two faces of one pathology. Clin Auton Res (2015) 1.40
Nomograms for severity of aortic valve stenosis using peak aortic valve pressure gradient and left ventricular ejection fraction. Eur J Echocardiogr (2009) 1.39
Single coronary artery with anomalous origin from the right sinus Valsalva. Clin Res Cardiol (2006) 1.35
Caveolae and caveolin in transmembrane signaling: Implications for human disease. Cardiovasc Res (2006) 1.25
Activation of tubular epithelial cells in diabetic nephropathy. Diabetes (2002) 1.24
Generation of mature murine monocytes from heterogeneous bone marrow and description of their properties. J Histochem Cytochem (2011) 1.18
Protein kinase C in the human heart: differential regulation of the isoforms in aortic stenosis or dilated cardiomyopathy. Mol Cell Biochem (2007) 1.17
Disruption of caveolin-1 leads to enhanced nitrosative stress and severe systolic and diastolic heart failure. Biochem Biophys Res Commun (2005) 1.14
Remote preconditioning by infrarenal occlusion of the aorta protects the heart from infarction: a newly identified non-neuronal but PKC-dependent pathway. Cardiovasc Res (2002) 1.10
The adverse cardiopulmonary phenotype of caveolin-1 deficient mice is mediated by a dysfunctional endothelium. J Mol Cell Cardiol (2008) 1.08
Differential phosphorylation-dependent regulation of constitutively active and muscarinic receptor-activated IK,ACh channels in patients with chronic atrial fibrillation. Cardiovasc Res (2007) 1.06
Remote preconditioning by infrarenal aortic occlusion is operative via delta1-opioid receptors and free radicals in vivo in the rat heart. Cardiovasc Res (2004) 1.04
Decreased caveolin-1 in atheroma: loss of antiproliferative control of vascular smooth muscle cells in atherosclerosis. Cardiovasc Res (2005) 1.02
Chronic NOS inhibition prevents adverse lung remodeling and pulmonary arterial hypertension in caveolin-1 knockout mice. Pulm Pharmacol Ther (2007) 1.02
The expression of macrophage migration inhibitory factor 1alpha (MIF 1alpha) in human atherosclerotic plaques is induced by different proatherogenic stimuli and associated with plaque instability. Atherosclerosis (2005) 1.00
Broken heart syndrome: Tako Tsubo cardiomyopathy associated with an overdose of the serotonin-norepinephrine reuptake inhibitor Venlafaxine. Eur Neuropsychopharmacol (2010) 0.95
Restrictive cardiomyopathy in a patient with primary hyperoxaluria type II. Clin Res Cardiol (2006) 0.94
Transcriptional regulation of Pim-1 kinase in vascular smooth muscle cells and its role for proliferation. Basic Res Cardiol (2009) 0.93
Transcriptional activation of DNA-dependent protein kinase catalytic subunit gene expression by oestrogen receptor-alpha. EMBO Rep (2010) 0.93
Right ventricular hypertrophy and apoptosis after pulmonary artery banding: regulation of PKC isozymes. Cardiovasc Res (2003) 0.93
Phenotypic overlap between hematopoietic cells with suggested angioblastic potential and vascular endothelial cells. J Hematother Stem Cell Res (2002) 0.91
Postconditioning with levosimendan reduces the infarct size involving the PI3K pathway and KATP-channel activation but is independent of PDE-III inhibition. Basic Res Cardiol (2009) 0.91
Use of oral endothelin-receptor antagonist bosentan in the treatment of portopulmonary hypertension. Transplantation (2004) 0.91
Phenotypic overlap between monocytes and vascular endothelial cells. Adv Exp Med Biol (2003) 0.90
Correlation of heart-type fatty acid-binding protein with mortality and echocardiographic data in patients with pulmonary embolism at intermediate risk. Am Heart J (2010) 0.89
Prone positioning in the acute respiratory distress syndrome. N Engl J Med (2013) 0.88
Cell-specific and hypoxia-dependent regulation of human HIF-3α: inhibition of the expression of HIF target genes in vascular cells. Cell Mol Life Sci (2010) 0.88
Regulation of protein kinase C isozymes in volume overload cardiac hypertrophy. Mol Cell Biochem (2004) 0.87
Percutaneous lead implantation connected to an external device in stimulation-dependent patients with systemic infection--a prospective and controlled study. Pacing Clin Electrophysiol (2006) 0.87
Images in clinical medicine. Uni-, bi-, tri-, and quadricuspid aortic valves. N Engl J Med (2006) 0.86
Isolation and transduction of monocytes: promising vehicles for therapeutic arteriogenesis. Langenbecks Arch Surg (2006) 0.86
Apoptosis at a distance: remote activation of caspase-3 occurs early after myocardial infarction. Mol Cell Biochem (2006) 0.86
Interatrial septal closure devices and aortic perforation: a note of caution. J Invasive Cardiol (2009) 0.86
Nitric oxide synthases are crucially involved in the development of the severe cardiomyopathy of caveolin-1 knockout mice. Biochem Biophys Res Commun (2008) 0.85
The iron-regulatory peptide hepcidin is upregulated in the ischemic and in the remote myocardium after myocardial infarction. Peptides (2010) 0.84
Twiddler's syndrome in an adolescent patient with ICD during neurological and physical rehabilitation. Clin Res Cardiol (2008) 0.84
Differential regulation of cardiac protein kinase C isozyme expression after aortic banding in rat. Cardiovasc Res (2002) 0.84
Transplantation of bone marrow derived monocytes: a novel approach for augmentation of arteriogenesis in a murine model of femoral artery ligation. Am J Transl Res (2013) 0.83
Ischemic post-conditioning reduces infarct size of the in vivo rat heart: role of PI3-K, mTOR, GSK-3beta, and apoptosis. Mol Cell Biochem (2010) 0.83
Regulation of the HIF-system in human macrophages--differential regulation of HIF-α subunits under sustained hypoxia. Mol Immunol (2013) 0.83
Images in cardiovascular medicine. Aortic endocarditis caused by inadvertent left ventricular pacemaker lead placement. Circulation (2005) 0.83
Indocyanine green angiography: a new method to quantify collateral flow in mice. J Vasc Surg (2008) 0.82
Ischemic preconditioning promotes a transient, but not sustained translocation of protein kinase C and sensitization of adenylyl cyclase. Basic Res Cardiol (2003) 0.82
Chronic angiotensin II receptor blockade induces cardioprotection during ischemia by increased PKC-epsilon expression in the mouse heart. J Cardiovasc Pharmacol (2007) 0.82
Regulation of the Hif-system by micro-RNA 17 and 20a - role during monocyte-to-macrophage differentiation. Mol Immunol (2013) 0.82
Functional, morphologic, and molecular characterization of cold storage injury. J Vasc Surg (2012) 0.81
Meta-analysis of heart valve abnormalities in Parkinson's disease patients treated with dopamine agonists. Mov Disord (2007) 0.81
Impact of Hey2 and COUP-TFII on genes involved in arteriovenous differentiation in primary human arterial and venous endothelial cells. Basic Res Cardiol (2013) 0.81
Results of angioplasty (with or without stent) at the site of a narrowed coronary anastomosis of the left internal mammary artery graft or via the internal mammary artery. Am J Cardiol (2004) 0.81
Fluorochrome-based definition of naturally occurring Foxp3(+) regulatory T cells of intra- and extrathymic origin. Eur J Immunol (2014) 0.81
Cardioprotection by ischemic postconditioning is abrogated in hypertrophied myocardium of spontaneously hypertensive rats. J Cardiovasc Pharmacol (2013) 0.81
Ephrin-A1/EphA4-mediated adhesion of monocytes to endothelial cells. Biochim Biophys Acta (2013) 0.81
MiR-134-mediated β1 integrin expression and function in mesenchymal stem cells. Biochim Biophys Acta (2013) 0.80
OxLDL and macrophage survival: essential and oxygen-independent involvement of the Hif-pathway. Basic Res Cardiol (2011) 0.80
Effects of the PPARγ agonist pioglitazone on coronary atherosclerotic plaque composition and plaque progression in non-diabetic patients: a double-center, randomized controlled VH-IVUS pilot-trial. Heart Vessels (2014) 0.79
Uncoupled eNOS annihilates neuregulin-1β-induced cardioprotection: a novel mechanism in pharmacological postconditioning in myocardial infarction. Mol Cell Biochem (2012) 0.79
Tetanus toxoid-pulsed monocyte vaccination for augmentation of collateral vessel growth. J Am Heart Assoc (2014) 0.79
Dexrazoxane prevents the development of the impaired cardiac phenotype in caveolin-1-disrupted mice. J Cardiovasc Pharmacol (2013) 0.79
The lysosomal transfer of LDL/cholesterol from macrophages into vascular smooth muscle cells induces their phenotypic alteration. Cardiovasc Res (2012) 0.79
Stimulation of adenosine A2b receptors blocks apoptosis in the non-infarcted myocardium even when administered after the onset of infarction. Mol Cell Biochem (2009) 0.79
Mechanisms of myocardial remodeling: ramiprilat blocks the expressional upregulation of protein kinase C-epsilon in the surviving myocardium early after infarction. J Cardiovasc Pharmacol (2003) 0.78
A novel activation process of protein kinase C in the remote, non-ischemic area of an infarcted heart is mediated by angiotensin-AT1 receptors. J Mol Cell Cardiol (2003) 0.78
Comparative morphometric and immunohistological assessment of the development of restenosis after arterial injury and a cholesterol-rich diet in apolipoprotein E -/-mice and C57BL/6 control mice. Coron Artery Dis (2005) 0.78
From bench to bedside: chromogranin B-a promising novel biomarker in heart failure. Congest Heart Fail (2011) 0.77
Regulation of the isozymes of protein kinase C in the surviving rat myocardium after myocardial infarction: distinct modulation for PKC-alpha and for PKC-delta. Basic Res Cardiol (2002) 0.77
Atrial fibrillation is associated with high levels of monocyte-platelet-aggregates and increased CD11b expression in patients with aortic stenosis. Thromb Haemost (2016) 0.77
Transregulation of the alpha2-adrenergic signal transduction pathway by chronic beta-blockade: a novel mechanism for decreased platelet aggregation in patients. J Cardiovasc Pharmacol (2005) 0.77
[Which kinds of distress do partners or spouses of cardiac arrhythmias patients exhibit?]. Z Psychosom Med Psychother (2006) 0.77
SPIRIT Women, evaluation of the safety and efficacy of the XIENCE V everolimus-eluting stent system in female patients: referral time for coronary intervention and 2-year clinical outcomes. EuroIntervention (2012) 0.77
Multicentre evaluation of a second generation point-of-care assay with an extended range for the determination of N-terminal pro-brain natriuretic peptide. Clin Lab (2012) 0.76
Valvular heart disease in Parkinson's disease patients treated with dopamine agonists: a reader-blinded monocenter echocardiography study. Mov Disord (2007) 0.76
Pharmacological postconditioning by bolus injection of phosphodiesterase-5 inhibitors vardenafil and sildenafil. Mol Cell Biochem (2013) 0.76
Guillain-Barré syndrome and catecholamine therapy. A potential risk for developing takotsubo cardiomyopathy? Int J Cardiol (2012) 0.75
Stored red blood cells impair vascular function in vivo. Transfusion (2014) 0.75
Letter by Ibrahim et al regarding article "Circulating endothelial progenitor cells do not contribute to plaque endothelium in murine atherosclerosis". Circulation (2010) 0.75
A prospective, randomized trial of continuous lateral rotation ("kinetic therapy") in patients with cardiogenic shock. Clin Res Cardiol (2012) 0.75
Chronic diarrhea as the initial clinical manifestation of light-chain amyloidosis with cardiac involvement despite negative duodenal and rectal biopsies. Exp Clin Cardiol (2013) 0.75
Chromogranin B in calpain-mediated hypertrophic signaling--the chicken, the egg, or even both...? Circ Res (2011) 0.75
Comparison of external and intravascular cooling to induce hypothermia in patients after CPR. Ger Med Sci (2006) 0.75
3-T magnetic resonance for determination of aortic valve area: a comparison to echocardiography. Scand Cardiovasc J (2014) 0.75